...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Diagnosis of α-1-Antitrypsin Deficiency: An Algorithm of Quantification, Genotyping, and Phenotyping
【24h】

Diagnosis of α-1-Antitrypsin Deficiency: An Algorithm of Quantification, Genotyping, and Phenotyping

机译:α-1-抗胰蛋白酶缺乏症的诊断:量化,基因分型和表型的算法。

获取原文

摘要

Background: Laboratory testing in suspected α-1-antitrypsin (A1AT) deficiency involves analysis of A1AT concentrations and identification of specific alleles by genotyping or phenotyping. The purpose of this study was to define and evaluate a strategy that provides reliable laboratory evaluation of A1AT deficiency.Methods: Samples from 512 individuals referred for A1AT phenotype analysis were analyzed by quantification, phenotype, and genotype. A1AT concentrations were measured by nephelometry. Phenotype analysis was performed by isoelectric focusing electrophoresis. The genotype assay detected the S and Z deficiency alleles by a melting curve analysis.Results: Of the 512 samples analyzed, 2% of the phenotype and genotype results were discordant. Among these 10 discordant results, 7 were attributed to phenotyping errors. On the basis of these data we formulated an algorithm, according to which we analyzed samples by genotyping and quantification assays, with a reflex to phenotyping when the genotype and quantification results were not concordant. Retrospective analyses demonstrated that 4% of samples submitted for genotype and quantitative analysis were reflexed to phenotyping. Of the reflexed samples, phenotyping confirmed the genotype result in 85% of cases. In the remaining 15%, phenotyping provided further information, including identifying rare deficiency alleles and suggesting the presence of a null allele, and allowed for a more definitive interpretation of the genotype result.Conclusions: The combination of genotyping and quantification, with a reflex to phenotyping, is the optimal strategy for the laboratory evaluation of A1AT deficiency.
机译:背景:针对可疑的α-1-抗胰蛋白酶(A1AT)缺乏症的实验室测试包括分析A1AT浓度并通过基因分型或表型鉴定特定等位基因。这项研究的目的是定义和评估一种策略,为A1AT缺乏症的实验室评估提供可靠的方法。方法:通过定量,表型和基因型分析来自512名进行A1AT表型分析的个体的样本。通过浊度法测量A1AT浓度。表型分析通过等电聚焦电泳进行。基因型分析通过熔解曲线分析检测到S和Z缺乏等位基因。结果:在512个样本中,2%的表型和基因型结果不一致。在这10个不一致的结果中,有7个归因于表型错误。在这些数据的基础上,我们制定了一种算法,根据该算法,我们通过基因分型和定量分析对样本进行了分析,当基因型和定量结果不一致时,可以对表型进行反思。回顾性分析表明,提交基因型和定量分析的样本中有4%反映了表型。在反射样品中,表型确定了85%的病例的基因型结果。在剩下的15%中,表型提供了进一步的信息,包括鉴定罕见的缺陷等位基因并提示存在无效等位基因,并允许对基因型结果进行更明确的解释。结论:基因型和定量结合,对表型分析是实验室评估A1AT缺乏症的最佳策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号